Compugen
Anat Cohen-Dayag has been the President & CEO of Compugen since December 2002. Prior to this, they served as Head of R&D at Mindsense Biosystems Ltd from January 1999 to December 2002. From January 1996 to December 1999, Cohen-Dayag worked as a Scientist at Orgenics Ltd., a subsidiary of Inverness Medical.
Dr. Anat Cohen-Dayag is a life sciences researcher who earned their Ph.D. from the Weizmann Institute of Science. Anat also holds a Master of Science from the same school. Dr. Cohen-Dayag's research focuses on understanding the mechanisms of diseases and developing new treatments.
Some direct reports include Eran Ophir - Vice President, Research and Drug Discovery, Yaron Turpaz - SVP and Senior Advisor, Computational Discovery, and Henry Adewoye - SVP & Chief Medical Officer.
This person is not in any offices
Compugen
1 followers
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.